Scribe Therapeutics Inc.
SCTX
IPO
$29.41
-$1.93-6.16%
NASDAQ
IPO Factors
Debt Ratio
Growth Ratio
Industry
Institutional Support
Investment
IPO Size
Management
Market Reaction
Profitability
Revenue
Revenue Growth
Syndicate Size
Valuation
Headlines
9/8/2026
-
MarketBeat
9/7/2026
-
MarketBeat
9/4/2026
-
MarketBeat
9/4/2026
-
The Cerbat Gem
9/3/2026
-
Insider Monkey
9/3/2026
-
The Cerbat Gem
9/3/2026
-
MarketBeat
Scribe Therapeutics (NASDAQ:SCTX) Issues Quarterly Earnings Results, Beats Expectations By $2.36 EPS
9/2/2026
-
MarketBeat
9/2/2026
-
TipRanks: TheFly
9/2/2026
-
Globe Newswire
9/2/2026
-
MarketBeat
9/1/2026
-
Globe Newswire
8/31/2026
-
The Cerbat Gem
8/31/2026
-
MarketBeat
8/31/2026
-
24/7 Wall St.
8/31/2026
-
TipRanks: TheFly
8/28/2026
-
MarketBeat
8/26/2026
-
MarketBeat
8/25/2026
-
MarketBeat
8/24/2026
-
MarketBeat
8/20/2026
-
MarketBeat
8/20/2026
-
TipRanks
8/19/2026
-
MarketBeat
8/18/2026
-
TipRanks: TheFly
8/18/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, September 2, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Jun 7 and 11 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
510 626 8587
Address
1150 Marina Village Pkwy
Alameda, CA 94501
Alameda, CA 94501
Country
Year Founded
Business Description
Sector
Scribe Therapeutics Inc. operates as a clinical-stage biotechnology company, focuses on research and developing genetic medicines using CRISPR-based tools to address the root cause of diseases...
more